Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials

Published:2019-10 Issue:10 Volume:41 Page:2137-2152.e12
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Zhu Houyong,Xu Xiaoqun,Fang Xiaojiang,Zheng Jianwu,Zhao Qian,Chen Tielong,Huang Jinyu

Funder

Zhejiang Natural Science Foundation

Science Technology Department of Zhejiang Province

Health and Family Planning Commission of Zhejiang Province

Hangzhou Health Science and Technology Project

Hangzhou Science and Technology Bureau Project

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference57 articles.

1. Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC State-of-the-Art Review;Taqueti;J Am Coll Cardiol,2018

2. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the women's ischemia syndrome evaluation study and the st james women take heart Project;Gulati;Arch Intern Med,2009

3. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events;Jespersen;Eur Heart J,2012

4. The economic burden of angina in women with suspected ischemic heart disease: results from the national Institutes of health–national heart, Lung, and blood institute–sponsored women's ischemia syndrome evaluation;Shaw;Circulation,2006

5. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study;Johnson;Eur Heart J,2006

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronary microvascular disease in women: epidemiology, mechanisms, evaluation, and treatment;Canadian Journal of Physiology and Pharmacology;2024-05-10

2. Ranolazine for improving coronary microvascular function in patients with nonobstructive coronary artery disease: a systematic review and meta-analysis with a trial sequential analysis of randomized controlled trials;Quantitative Imaging in Medicine and Surgery;2024-02

3. Anti-ischemic and pleiotropic effects of ranolazine in chronic coronary syndromes;The American Journal of the Medical Sciences;2023-12

4. Coronary microvascular dysfunction and cardiovascular disease: Pathogenesis, associations and treatment strategies;Biomedicine & Pharmacotherapy;2023-08

5. Coronary Microvascular Dysfunction: What Clinicians and Investigators Should Know;Current Atherosclerosis Reports;2023-06-20